John Applegate

John Applegate is an experienced financial executive currently serving as the Chief Financial Officer at Zephyr AI since April 2024. Prior to this role, John held the same position at Verge Genomics from October 2022 to April 2024 and served as Vice President of Finance & Accounting at Valo Health between May 2019 and October 2022. John’s extensive background includes significant roles at Biogen, where responsibilities included Senior Director, Head of R&D Finance, and Director of Program Leadership, overseeing collaborations with Eisai and Genentech. Additional positions include Director of R&D Financial Operations at Art Technology Group and Vice President of Business Development at Houston Street Exchange, as well as consulting experience at Mercer Management Consulting. John earned an MBA from Harvard Business School and a BA in Economics from Northwestern University.